16-57360523-T-A
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3
The NM_002990.5(CCL22):c.160T>A(p.Tyr54Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000805 in 1,614,090 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002990.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CCL22 | NM_002990.5 | c.160T>A | p.Tyr54Asn | missense_variant | Exon 2 of 3 | ENST00000219235.5 | NP_002981.2 | |
| CCL22 | XM_047434449.1 | c.199T>A | p.Tyr67Asn | missense_variant | Exon 3 of 4 | XP_047290405.1 | ||
| CCL22 | XM_047434450.1 | c.160T>A | p.Tyr54Asn | missense_variant | Exon 3 of 4 | XP_047290406.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CCL22 | ENST00000219235.5 | c.160T>A | p.Tyr54Asn | missense_variant | Exon 2 of 3 | 1 | NM_002990.5 | ENSP00000219235.4 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152238Hom.: 0 Cov.: 33 show subpopulations
GnomAD4 exome AF: 0.00000752 AC: 11AN: 1461852Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 727226 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152238Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74372 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.160T>A (p.Y54N) alteration is located in exon 2 (coding exon 2) of the CCL22 gene. This alteration results from a T to A substitution at nucleotide position 160, causing the tyrosine (Y) at amino acid position 54 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at